Understanding J&J’s Risk From New FDA Label Warning For Invokana

Earlier this week, THE FDA gave a jolt to Johnson & Johnson‘s diabetes business when it concluded that J&J must include a label warning that patients using its diabetes drug Invokana are at a higher risk of leg and foot amputation.

Vía Forbes Real Time http://ift.tt/2qxMEAa